Tilray Brands, Inc. (NASDAQ:TLRY) Receives $2.00 Consensus Target Price from Analysts

Shares of Tilray Brands, Inc. (NASDAQ:TLRY) have been given a consensus rating of “Hold” by the seven brokerages that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, three have given a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $2.00.

Several research firms recently commented on TLRY. Atb Cap Markets lowered shares of Tilray Brands from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 9th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tilray Brands in a research note on Wednesday, October 8th. Zelman & Associates reiterated a “neutral” rating on shares of Tilray Brands in a report on Tuesday, July 29th. Wall Street Zen upgraded shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Saturday. Finally, Jefferies Financial Group upped their price target on shares of Tilray Brands from $1.50 to $2.00 and gave the company a “buy” rating in a research report on Monday, August 25th.

Insider Activity at Tilray Brands

In other Tilray Brands news, CEO Irwin D. Simon purchased 165,000 shares of the stock in a transaction dated Wednesday, July 30th. The shares were acquired at an average price of $0.61 per share, for a total transaction of $100,650.00. Following the completion of the acquisition, the chief executive officer owned 3,941,633 shares of the company’s stock, valued at $2,404,396.13. This represents a 4.37% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.84% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tilray Brands

A number of large investors have recently made changes to their positions in the business. J.W. Cole Advisors Inc. boosted its holdings in shares of Tilray Brands by 203.2% during the second quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock worth $30,000 after purchasing an additional 48,177 shares during the period. Cerity Partners LLC purchased a new stake in Tilray Brands in the 1st quarter worth approximately $31,000. Capital Management Associates Inc boosted its stake in shares of Tilray Brands by 100.0% during the 1st quarter. Capital Management Associates Inc now owns 50,760 shares of the company’s stock valued at $33,000 after buying an additional 25,380 shares during the period. Fifth Lane Capital LP boosted its stake in shares of Tilray Brands by 400.0% during the 1st quarter. Fifth Lane Capital LP now owns 50,000 shares of the company’s stock valued at $33,000 after buying an additional 40,000 shares during the period. Finally, Zuckerman Investment Group LLC purchased a new position in shares of Tilray Brands during the 1st quarter valued at $33,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Brands Stock Down 5.3%

TLRY stock opened at $1.60 on Friday. Tilray Brands has a 12 month low of $0.35 and a 12 month high of $2.32. The firm has a market cap of $1.76 billion, a PE ratio of -0.70 and a beta of 1.98. The firm has a 50 day simple moving average of $1.28 and a 200 day simple moving average of $0.77. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.62 and a quick ratio of 1.56.

Tilray Brands (NASDAQ:TLRY) last released its earnings results on Thursday, October 9th. The company reported $0.00 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.03. Tilray Brands had a negative net margin of 258.54% and a negative return on equity of 6.79%. The business had revenue of $209.50 million during the quarter, compared to analyst estimates of $205.75 million. Equities research analysts forecast that Tilray Brands will post -0.2 earnings per share for the current fiscal year.

Tilray Brands Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.